A CRE Industry First: Newmark, CDC-NIOSH & FDA Leaders Discuss a Path Forward

Newmark participates in an industry-first discussion with FDA and CDC-NIOSH experts on the intersection of the scientific, medical, regulatory and CRE responses to COVID-19.

Inclusive of all CRE sectors and the impacts on community, transportation, supply chain and mobility.

Perspectives is a collection of stories and commentary from the point of view of our people, about capabilities, expertise, and insights on the ever-changing world of commercial real estate. Views and opinions expressed belong to the authors and contributors of each post.

For more information, read about website terms of use.

Related Content